Literature DB >> 18704016

Nitric oxide and vascular reactivity in sepsis.

Daniel Fernandes, Jamil Assreuy.   

Abstract

Sepsis and septic shock are major causes of morbidity and mortality in critically ill patients. Sepsis and septic shock induce a profound fall in the peripheral vascular tone. NO has been implicated as a key player in vascular changes of sepsis and septic shock. In this brief review, two points are focused in greater detail: first, the involvement of guanylate cyclase and potassium channels in NO vascular effects in sepsis; second, the role played by NO and its two effectors in the long-lasting modifications of vascular reactivity in sepsis. Some recent developments in the area are reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704016     DOI: 10.1097/SHK.0b013e3181818518

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  20 in total

1.  NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite.

Authors:  Bahar Tunctan; Ayse Nihal Sari; Meltem Kacan; Demet Unsal; C Kemal Buharalioglu; Seyhan Sahan-Firat; Belma Korkmaz; John R Falck; Kafait U Malik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-09-05       Impact factor: 3.072

2.  Early potassium channel blockade improves sepsis-induced organ damage and cardiovascular dysfunction.

Authors:  R Sordi; D Fernandes; B T Heckert; J Assreuy
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide.

Authors:  C Kemal Buharalioglu; Belma Korkmaz; Tuba Cuez; Seyhan Sahan-Firat; Ayse Nihal Sari; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-05-06       Impact factor: 4.080

4.  Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats.

Authors:  Bahar Tunctan; Belma Korkmaz; Tuba Cuez; C Kemal Buharalioglu; Seyhan Sahan-Firat; John Falck; Kafait U Malik
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-11       Impact factor: 4.080

5.  Reactive oxygen species and small-conductance calcium-dependent potassium channels are key mediators of inflammation-induced hypotension and shock.

Authors:  Anje Cauwels; Elke Rogge; Ben Janssen; Peter Brouckaert
Journal:  J Mol Med (Berl)       Date:  2010-05-25       Impact factor: 4.599

6.  Vascular BK channel deficiency exacerbates organ damage and mortality in endotoxemic mice.

Authors:  Hui Xu; Youping Wang; Hannah Garver; James J Galligan; Gregory D Fink
Journal:  J Cardiovasc Pharmacol       Date:  2012-03       Impact factor: 3.105

7.  A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats.

Authors:  Tuba Cuez; Belma Korkmaz; C Kemal Buharalioglu; Seyhan Sahan-Firat; John Falck; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-07       Impact factor: 4.080

8.  Pneumonia-induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters.

Authors:  Regina Sordi; Octávio Menezes-de-Lima; Ana M Della-Justina; Edir Rezende; Jamil Assreuy
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

9.  Effects of angiotensin II type 1 receptor antagonist on rats with septic shock.

Authors:  Jianrong Guo; Wei Guo; Xiaoju Jin; Yang Liu; Lei Zhang; Jianping Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes.

Authors:  Nagwa A Lachine; Abdel Aziz Elnekiedy; Magdy Helmy Megallaa; Gihane I Khalil; Mohamed A Sadaka; Kamel H Rohoma; Heba S Kassab
Journal:  Ther Adv Endocrinol Metab       Date:  2016-03-10       Impact factor: 3.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.